[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357137-105":59,"doc-detail-357137-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proof-of-principle-4-marker-spatial-profiling-reveals-distinct-location-independent-immune-clusters-in-biliary-tract-cancers","Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers","","Biliary tract cancers are aggressive malignancies with limited options and poor prognosis. This study uses multiplex immunofluorescence on pre-treatment tumor samples from 11 advanced patients, profiling CD4, CD8, CD20, and CD163 across 198 regions of interest and ~400,000 segmented cells at the invasive margin. Unsupervised spatial analysis identified two immune phenotypes with distinct architectures and different organizing hubs. A subset showed enrichment of co-occurring TP53 and ARID1A alterations in the B-cell phenotype; survival differences were not overall, but baseline CD20/CD8 and CD163 levels correlated with improved outcomes after adjuvant cisplatin/gemcitabine.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proof-of-principle-4-marker-spatial-profiling-reveals-distinct-location-independent-immune-clusters-in-biliary-tract-cancers/357137/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proof-of-principle-4-marker-spatial-profiling-reveals-distinct-location-independent-immune-clusters-in-biliary-tract-cancers/357137.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What immune markers were used in the multiplex immunofluorescence profiling?","Question",{"text":112,"@type":113},"The study stained pre-treatment tumor samples for CD4, CD8, CD20, and CD163 to represent T cells, B cells, and macrophages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many regions of interest and cells were analyzed?",{"text":117,"@type":113},"Analysis covered 198 regions of interest at the invasive tumor margin, with approximately 400,000 individual cells segmented and phenotyped.",{"name":119,"@type":110,"acceptedAnswer":120},"What survival-related associations were observed between immune phenotypes?",{"text":121,"@type":113},"Overall and progression-free survival did not differ significantly between immune phenotypes, but in patients receiving adjuvant cisplatin/gemcitabine alone, lower baseline CD20/CD8 fractions and higher baseline CD163 abundance were associated with improved survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357137,1790179583,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 28 May 2026  \nDOI 10.3389/pore.2026.1612389  \nOPEN ACCESS  \nEDITED BY  \nAnna Sebestyén,  \nSemmelweis University, Hungary  \n*CORRESPONDENCE  \nAndrea Casadei-Gardini,  \n [casadeigardini.andrea@hsr.it](casadeigardini.andrea@hsr.it)[ ](casadeigardini.andrea@hsr.it)Federica Pedica,  \n [pedica.federica@hsr.it](pedica.federica@hsr.it)[ ](pedica.federica@hsr.it)Chiara Balestrieri,  \n [balestrieri.chiara@hsr.it](balestrieri.chiara@hsr.it)  \n†These authors have contributed equally to this work  \nRECEIVED 13 February 2026  \nREVISED 01 May 2026  \nACCEPTED 19 May 2026  \nPUBLISHED 28 May 2026  \nCITATION  \nRossari F, Sala M, Rimini M, Camera S, Persano M, Tonon G, Bonini C, Cangi MG, Pecciarini L, Doglioni C, Ponzoni M, Balestrieri C, Pedica F and  \nCasadei-Gardini A (2026) Proof-ofprinciple 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers.  \nPathol. Oncol. Res. 32:1612389 .  \ndoi: 10.3389/pore.2026.1612389  \nCOPYRIGHT  \n© 2026 Rossari, Sala, Rimini, Camera, Persano, Tonon, Bonini, Cangi, Pecciarini, Doglioni, Ponzoni, Balestrieri, Pedica and Casadei-Gardini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nProof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers  \nFederico Rossari 1,2†, Michele Sala 3,4,5†, Margherita Rimini 1,2, Silvia Camera 1, Mara Persano 1, Giovanni Tonon 2,3,  \nChiara Bonini 2,6, Maria Giulia Cangi 7, Lorenza Pecciarini 7, Claudio Doglioni 2,7, Maurilio Ponzoni 2,7, Chiara Balestrieri 3,6*†, Federica Pedica 2,7*† and Andrea Casadei-Gardini 1,2*†  \n1Department of Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy, 2“Vita-Salute” San Raffaele University, Milan, Italy, 3Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy, 4University of Milan, Milan, Italy, 5Politecnico di Milano, Milan, Italy, 6Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy, 7Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy  \nBiliary tract cancers (BTCs) are aggressive malignancies with limited treatment options. Despite advances with durvalumab plus chemotherapy, prognosis remains poor. The tumor immune microenvironment (TIME) is increasingly recognized as a determinant of immunotherapy response, yet its spatial organization in BTC is poorly understood. We applied multiplex immunofluorescence to pre-treatment tumor samples from 11 patients with advanced BTC, staining for CD4, CD8, CD20, and CD163 to identify T cells, B cells, and macrophages. Across 198 regions of interest sampled at the invasive tumor margin, approximately 400,000 individual cells were segmented and phenotyped. Spatial organization was analyzed using hierarchical clustering, distance-based approaches, and cellular neighborhood classification. Unsupervised analysis identified two distinct immune phenotypes, one enriched in CD4+ T cells and CD163+ macrophages and the other in CD8+ T cells and CD20+ B cells. These phenotypes displayed distinct spatial architectures, with CD4+ T cells and CD20+ B cells acting as organizing hubs, respectively. Targeted sequencing, available for a subset of cases, showed a higher frequency of co-occurring TP53 and ARID1A alterations in the B-cell–enriched phenotype. No statistically significant differences in overall or progression-free survival were observed between immune phenotypes. However, among patients treated with adjuvant cisplatin/ge","cbCairGJekN9Sl4r","https://ap.wps.com/l/cbCairGJekN9Sl4r","pdf",7857482,13,"English","# Introduction\n# Methods\n## Multiplex immunofluorescence and spatial profiling\n## Clustering and neighborhood analysis\n# Results\n## Immune phenotypes and spatial architectures\n## Genomic associations in a subset\n## Survival and treatment-related biomarkers\n# Conclusion","[{\"question\":\"What immune markers were used in the multiplex immunofluorescence profiling?\",\"answer\":\"The study stained pre-treatment tumor samples for CD4, CD8, CD20, and CD163 to represent T cells, B cells, and macrophages.\"},{\"question\":\"How many regions of interest and cells were analyzed?\",\"answer\":\"Analysis covered 198 regions of interest at the invasive tumor margin, with approximately 400,000 individual cells segmented and phenotyped.\"},{\"question\":\"What survival-related associations were observed between immune phenotypes?\",\"answer\":\"Overall and progression-free survival did not differ significantly between immune phenotypes, but in patients receiving adjuvant cisplatin/gemcitabine alone, lower baseline CD20/CD8 fractions and higher baseline CD163 abundance were associated with improved survival.\"}]","Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers | PDF",1790129110,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3becd3fea6178927ca8d4a4c8cd29bf.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51c45e15b7a2764d8c2579199fce3590.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5110e7b74c92b74e2442f1311c060d0c.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b00b0c605a42fe5ea96b6d04fc168aa8.webp",980,1385]